JRC Publications Repository

JRC Publications Repository >

Browsing by Author APOSTOLIDIS Christos

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:   
Sort by: In order: Results/Page Authors/Record:
Showing results 54 to 73 of 146
Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2013Half-lives of 221Fr, 217At, 213Bi, 213Po and 209Pb from the 225Ac decay seriesSULIMAN GABRIEL; POMME Stefaan; MAROULI Maria; VAN AMMEL Raf; STROH HEIKO; JOBBAGY Viktor; PAEPEN Jan; DIRICAN A.; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos, et alArticles in Journals
2000High-Linear Energy Transfer (LET) alpha vs Low-LET beta Emitters in Radioimmunotherapy of Solid Tumors: Therapeutic Efficacy and Dose-Limiting Toxicity of 213Bi- vs 90Y-Labeled CO17-1A Fab' Fragments in a Human Colonic Cancer Model.BEHR T.m.; BEHE M.; STABIN M.g.; WEHRMANN E.; APOSTOLIDIS Christos; MOLINET Roger; STRUTZ F.; FAYYAZI A.; WIELAND E.; GRATZ S.t., et alArticles in Journals
2012High-resolution alpha-particle spectrometry of the 230U decay seriesMAROULI MARIA; POMME Stefaan; PAEPEN Jan; VAN AMMEL Raf; JOBBAGY VIKTOR; DIRICAN ABDULLAH; SULIMAN GABRIEL; STROH HEIKO; APOSTOLIDIS Christos; ABBAS Kamel, et alContributions to Conferences
2001Highly Specific Tumor Binding of a 213Bi Labeled Monoclonal Antibody against Mutant E-Cadherin Suggests its Usefulness for Locoregional alpha-Radioimmunotherapy of Diffuse-Type Gastric Cancer.SENEKOWITSCH-SCHMIDTKE R.; SCHUHMACHER C.; BECKER K.; NIKULA T.k.; SEIDL C.; BECKER I.; MIEDERER M.; APOSTOLIDIS Christos; ADAM C.; HUBER Roswitha, et alArticles in Journals
1997Homoscorpionates (Hydridotris(1-pyrazoly)borato Complexes) of the Trivalent 4f Ions. The Crystal and Molecular Structure of ((HB(N2C3H3)3)3LnIII, (Ln=Pr,Nd).APOSTOLIDIS Christos; REBIZANT Jean; VON AMMON R.; DORNBERGER Ernst; MUELLER J.; POWIETZKA B.; NUBER B.Articles in Journals
2004Importance of Receptor Density in Alpha Radioimmunotherapy in B Cell Malignancies: an In-vitro Study.VANDENBULCKE Katja; THIERENS H.; OFFNER Fritz; JANSSENS A.; DE GELDER V.; BACHER K.; PHILIPPE Jan; DE VOS F.; DIERCKX R.; APOSTOLIDIS Christos, et alArticles in Journals
2007An Improved Method for the Production of Ac-225/Bi-213 from Th-229 for Targeted Alpha TherapyZIELINSKA Barbara; APOSTOLIDIS CHRISTOS; BRUCHERTSEIFER FRANK; MORGENSTERN ALFREDArticles in Journals
2009In vitro and in vivo comparison of 226Th and 213Bi-labelled radioconjugates for target alpha therapyBRUCHERTSEIFER Frank; MORGENSTERN Alfred; FRIESEN CLAUDIA; ROSCHER MAREIKE; MILTNER E.; PFOST B.; SENEKOWITSCH-SCHMIDTKE R.; ABBAS Kamel; APOSTOLIDIS ChristosContributions to Conferences
2003In Vitro Evaluation of 231Bi-Rituximab versus External Gamma Irradiation for the Treatment of B-CLL Patients: Relative Biological Efficacy with Respect to Apoptosis Induction and Chromosomal Damage.VANDENBULCKE K.; DE VOS F.; OFFNER Fritz; PHILIPPE Jan; APOSTOLIDIS Christos; MOLINET Roger; NIKULA T.k.; BACHER K.; DE GELDER V.; VRAL A., et alArticles in Journals
2005In Vitro Evaluation of High-LET 213Bi-Therapy Combined to Other Therapeutic Agents for the Treatment of B-CLL.VANDENBULCKE Katja, et alArticles in Journals
2006In Vitro Screening for Synergism of High-linear Energy Transfer 213Bi-radiotherapy with other Therapeutic Agents for the Treatment of B-cell Chronic Lymphocytic LeukemiaVANDENBULCKE K., et alArticles in Journals
2009Inhibition ofMicrometastatic Prostate Cancer Cell Spread in Animal Models By 213BilabeledMultipleTargeted Alpha-RadioimmunoconjugatesLI Y., et alArticles in Journals
2012Interaction of advanced oxide fuels with sodium for Generation IV Sodium cooled Fast ReactorsSMITH ANNA, et alContributions to Conferences
2013Interaction of advanced oxide fuels with sodium in operating conditions for Sodium-cooled Fast ReactorsSMITH ANNA, et alContributions to Conferences
2006Interaction of Radiolabeled Antibodies with Fungal Cells and Components of Immune System In Vitro and During Radioimmunotherapy of Experimental Fungal InfectionDADACHOVA E., et alArticles in Journals
2007Interim Analysis of Toxicity and Response in Phase 1 Trial of Systemic Targeted Alpha Therapy for Metastatic MelanomaRAJA C., et alArticles in Journals
2005Intralesional Targeted Alpha Therapy for Metastatic MelanomaALLEN Barry J., et alArticles in Journals
2010Investigation of Para-sulfonatocalix[n]arenes [n = 6, 8] as Potential Chelates for 230UMONTAVON Gilles, et alArticles in Journals
2010Investigation of para-sulfonatocalix[n]arenes [n = 6, 8] as potential chelates for 230U†MONTAVON Gilles, et alArticles in Journals
2006Local Trageting of Malignant Gliomas by the Difussible Peptidic Vector DOTAGA-substance PKNEIFEL S., et alArticles in Journals
Showing results 54 to 73 of 146

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top